Home About us Responsibility Research Products Authenticity Contact Us
Pharmaceutical Name : Testosterone Cypionate
Proprietary Name    : Cypionez 250TM
Dosage form        : 250mg/ml multidose vial
Cypionez 250TM is a highly anabolic and androgenic hormone, it has an anabolic (muscle building) as well as anabolic rating of 100 each, respectively. Cypionez 250TM exerts the majority of its effects by promoting increased nitrogen retention in the muscle. Cypionez 250TM is also known to increases levels of the growth factor IGF-1 in both the muscle tissue as well as the liver. Cypionez 250TM also increases the activity of satellite cells, which are cells that play an active role in repairing exercise-damaged muscle. Cypionez 250TM exerts these effects primarily by genomic mechanisms, meaning that it binds to the androgen receptor thus initiating gene transcription. This stimulation of the AR promotes various of the AR dependant mechanisms for both muscle gain and fat loss, as well as reducing catabolic glucocorticoid hormones, and increasing red blood cell production. Cypionez 250TM may even aid in protecting the heart against coronary disease. Cypionez 250TM binds to the AR on fat cells resulting in fat breakdown and also prevents new fat formation. Unfortunately, there is also a down side to Cypionez 250TM as well. Cypionez 250TM is metabolized in the body to the female hormone estrogen (via aromatization) by the aromatize enzyme. This can lead to some unwanted and nasty side effects; breast tissue growth in men (gynocomastia), some fat gain and even reduced fat breakdown, testicular shrinkage and water retention which can increase blood pressure. Cypionez 250TM is also a substrate for the 5alpha-reductase enzyme. Interaction with this enzyme converts the Cypionez 250TM to Dihydrotestosterone (DHT), a more androgenic form of the parent hormone, though a less anabolic one. DHT has a high binding affinity to the tissues of the scalp and prostate, resulting in hair loss in loss and making the prostate swell.
Copyright © 1997 Enzio Pharmaceuticals. All rights reserved.